| 卡培他滨联合奥沙利铂治疗晚期结肠癌的疗效观察 |
| |
| 引用本文： | 王运红. 卡培他滨联合奥沙利铂治疗晚期结肠癌的疗效观察[J]. 海南医学院学报, 2011, 17(4): 506-507,510 |
| |
| 作者姓名： | 王运红 |
| |
| 作者单位： | 广东省深圳市龙岗区沙湾医院肛肠科,广东深圳,518000 |
| |
| 基金项目： | 海南医学院科研基金学报项目 |
| |
| 摘 要： | 目的:探讨卡培他滨联合奥沙利铂治疗晚期结肠癌的疗效.方法:将我2009年11月～2010年12月收治的60例结肠癌患者随机分为对照组和治疗组,每组30例.对照组给予卡培他滨单药治疗;治疗组采用卡培他滨联合奥沙利铂治疗.比较两组患者的临床疗效、生存时间、1年和2年生存率以及不良反应发生情况,并进行统计分析.结果:治疗组临...
|
| 关 键 词： | 卡培他滨 奥沙利铂 结肠癌 |
Efficacy of combination treatment of capecitabine and oxaliplatin on advanced colorectal cancer |
| |
| WANG Yun-hong. Efficacy of combination treatment of capecitabine and oxaliplatin on advanced colorectal cancer[J]. Journal of Hainan Medical College, 2011, 17(4): 506-507,510 |
| |
| Authors: | WANG Yun-hong |
| |
| Affiliation: | WANG Yun-hong(Department of Anus and Intestine,Shawan Hospital in Longgang District of Shenzhen,Shenzhen 518000,China) |
| |
| Abstract: | Objective： To discuss the effect of combination therapy of capecitabine and oxaliplatin on advanced colorectal cancer（ACC）.Methods： A total of 60 patients with ACC were randomly divided into control group and treatment group by half.The patients in control group were only given capecitabine while the treatment group received the treatment of capecitabine and oxaliplatin.The survival time,survival rate of 1 year and 2 year and incidence of adverse reactions were compared between the two groups.Results： The clinical efficacy and control rate of the disease in the treatment group were significantly higher than that in the control group（P〈0.05）;The survival time,survival rates of 1 year and 2 year in the treatment group were also higher than the control group（P〈0.05）;there were no significant difference in the incidence of adverse reactions between the two groups（P〉 0.05）.Conclusions： The combination therapy of capecitabine and oxaliplatin is effective on treating ACC.It is worthy extensive application. |
| |
| Keywords: | Capecitabine； Oxaliplatin； Advanced colon cancer； |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
